Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pin-Nan Cheng

Showing results (41-50 of 137) with videos related to

Pageof 14
Sort By:
Hepato-Gastroenterology|October 24, 2003
Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigenKuo-Chih Tseng, Huan-Yao Lei, Pin-Nan Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 17, 2022
Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis CJyh-Jou Chen, Yen-Cheng Chiu, Pei-Lun Lee, et al.
Annals of Hepatology|October 22, 2014
HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis BPin-Nan Cheng, Yen-Cheng Chiu, Hung-Wen Tsai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 28, 2006
Seroprevalence of hepatitis E virus infection among institutionalized psychiatric patients in TaiwanPin-Nan Cheng, Ru-Hsueh Wang, I-Chin Wu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 6, 2005
A macrocycle/molecular-clip complex that functions as a quadruply controllable molecular switchPinn-Tsong Chiang, Pin-Nan Cheng, Chi-Feng Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 6, 2020
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from TaiwanHung-Chih Chiu, Yen-Cheng Chiu, Er-Hsiang Yang, et al.
Journal of Virus Eradication|April 17, 2023
Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agentsPin-Nan Cheng, Hung-Yu Sun, I-Che Feng, et al.
Antiviral Research|February 1, 2020
Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patientsWen-Chun Liu, I-Chin Wu, Yen-Cheng Chiu, et al.
World Journal of Gastroenterology|February 20, 2018
Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapyTien-Ching Lin, Yen-Cheng Chiu, Hung-Chih Chiu, et al.
Antiviral Therapy|March 4, 2014
Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled studyKuo-Chih Tseng, Chi-Yi Chen, Hung-Wen Tsai, et al.
Pageof 14

Showing results (41-50 of 137) with videos related to

Sort By:
Pageof 14
Hepato-Gastroenterology|October 24, 2003
Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigenKuo-Chih Tseng, Huan-Yao Lei, Pin-Nan Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 17, 2022
Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis CJyh-Jou Chen, Yen-Cheng Chiu, Pei-Lun Lee, et al.
Annals of Hepatology|October 22, 2014
HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis BPin-Nan Cheng, Yen-Cheng Chiu, Hung-Wen Tsai, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 28, 2006
Seroprevalence of hepatitis E virus infection among institutionalized psychiatric patients in TaiwanPin-Nan Cheng, Ru-Hsueh Wang, I-Chin Wu, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 6, 2005
A macrocycle/molecular-clip complex that functions as a quadruply controllable molecular switchPinn-Tsong Chiang, Pin-Nan Cheng, Chi-Feng Lin, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|September 6, 2020
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from TaiwanHung-Chih Chiu, Yen-Cheng Chiu, Er-Hsiang Yang, et al.
Journal of Virus Eradication|April 17, 2023
Reversibility of some oxidative stress markers in chronic hepatitis C patients after receiving direct-acting antiviral agentsPin-Nan Cheng, Hung-Yu Sun, I-Che Feng, et al.
Antiviral Research|February 1, 2020
Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patientsWen-Chun Liu, I-Chin Wu, Yen-Cheng Chiu, et al.
World Journal of Gastroenterology|February 20, 2018
Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapyTien-Ching Lin, Yen-Cheng Chiu, Hung-Chih Chiu, et al.
Antiviral Therapy|March 4, 2014
Efficacy of entecavir in chronic hepatitis B patients with persistently normal alanine aminotransferase: randomized, double-blind, placebo-controlled studyKuo-Chih Tseng, Chi-Yi Chen, Hung-Wen Tsai, et al.
Pageof 14